1. Pink Sheet

Senators Pressure US FDA To Issue New Guidance On Social Media Drug Promotion

 
• By Brenda Sandburg

Senators ask the agency to address the “regulatory loophole” permitting telehealth companies to promote prescription drugs without disclosing side effects and question if FDA has enforcement authority over third-party social media influencer promotions.

Social media drugs
Senators question FDA about promotion of prescription drugs on social media platforms. • Source: Shutterstock

The US Food and Drug Administration’s seven-year delay in updating guidance on social media promotion of prescription drugs has garnered the attention of two Senators, who want new guidance by the end of December.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Marketing & Advertising

More from Compliance